Grove City Pediatric Dentistry | |
5775 Hoover Rd Ste B Grove City OH 43123-7693 | |
(614) 350-5005 | |
(614) 350-5070 |
Full Name | Grove City Pediatric Dentistry |
---|---|
Speciality | Dentist - Pediatric Dentistry |
Location | 5775 Hoover Rd Ste B, Grove City, Ohio |
Authorized Official Name and Position | Kyle Beulke (OWNER/MEMBER) |
Authorized Official Contact | 4029682007 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Grove City Pediatric Dentistry 40 W Short St Worthington OH 43085-3561 Ph: (402) 968-2007 | Grove City Pediatric Dentistry 5775 Hoover Rd Ste B Grove City OH 43123-7693 Ph: (614) 350-5005 |
NPI Number | 1528726445 |
---|---|
Provider Enumeration Date | 12/08/2021 |
Last Update Date | 12/08/2021 |
Identifier | Type | State | Issuer |
---|---|---|---|
1528726445 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223P0221X | Dentist - Pediatric Dentistry | (* (Not Available)) | Primary |
News Archive
BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.
MEDNETWorld.com (MEDNET) will be featured at the March 1-4, 2010 Healthcare Information and Management Systems Society (HIMSS) annual conference in Atlanta, Ga. with a special demonstration at the "Interoperability Booth" by MEDNET Chief Architect Seonho Kim and a special presentation on March 4 in Session 246 by MEDNET CEO John Fraser on Identity Management in a Federated Nationwide Health Information Network (NHIN).
"Large sums of public money intended to ensure children in the developing world are immunized against disease are effectively being used to subsidize Big Pharma, doctors working in the field claim," the Guardian reports.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain.
› Verified 4 days ago
Granville Dental - M.alexandrunas, D.m.d., Inc. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4104 Broadway Ste D, Grove City, OH 43123 Phone: 614-871-0088 | |
Haid & Johnson Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3391 Farm Bank Way, Grove City, OH 43123 Phone: 614-594-2002 Fax: 614-594-0313 | |
Megan M Kottman Dds Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4218 Hoover Rd, Grove City, OH 43123 Phone: 614-539-2702 | |
Grove City Family Dentistry Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3031 Columbus Street, Grove City, OH 43123 Phone: 614-875-2153 Fax: 614-871-7471 | |
Grove City Smiles Michael Pappas Dds Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5775 Hoover Rd, Grove City, OH 43123 Phone: 614-864-2466 | |
Kiourtsis Orthodontics Incorporated Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4104 Broadway, Grove City, OH 43123 Phone: 614-875-6169 | |
Louis J Altomare & Bryan J Simone Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4104 Broadway, Grove City, OH 43123 Phone: 614-875-3141 |